July 2026

Engineered Gut Bacteria Show Potential as a New Weapon Against Pancreatic CancerResearchers have developed a genetically engineered probiotic bacterium that could offer a promising new approach for treating pancreatic cancer, one of the deadliest forms of cancer with limited therapeutic options. The study demonstrates that a modified strain of Bifidobacterium longum, a naturally occurring gut bacterium, can selectively colonize pancreatic tumors and stimulate a potent anti-tumor immune response.

Akums Drugs & Pharmaceuticals Ltd., India's leading Contract Development and Manufacturing Organization (CDMO), has announced the acquisition of Oriflame India's manufacturing business, marking its entry into the fast-growing color cosmetics manufacturing sector while significantly expanding its personal care and wellness portfolio.

The U.S. Food and Drug Administration (FDA) has approved Tylenol with Naproxen, the first nonprescription fixed-dose combination of acetaminophen and naproxen sodium for up to 12 hours of pain relief. The approval introduces a new over-the-counter (OTC) option for consumers seeking long-lasting, dual-action pain management without a prescription.